TSH Receptor Antibody (TRAb) Test: Uses & Results

When a patient walks into my clinic with a racing heart, unexplained weight loss, and a fine tremor in their hands, one of the first tests I consider is the TSH receptor antibody (TRAb). This blood test is the cornerstone of diagnosing Graves' disease—the most common cause of an overactive thyroid in young to middle-aged adults. Unlike other thyroid tests that measure hormone levels, TRAb looks for the autoantibody that actually drives the disease.

What Is TSH Receptor Antibody (TRAb)?

TRAb is an autoantibody that binds to the TSH receptor on thyroid cells. Instead of inhibiting the receptor, it mimics the action of thyroid-stimulating hormone (TSH), causing uncontrolled production of thyroid hormones T3 and T4. This leads to hyperthyroidism with characteristic symptoms.

The test is often requested when clinical signs suggest Graves' disease—especially when a patient has a diffuse goiter, orbitopathy (bulging eyes), or pretibial myxedema. In my experience, a positive TRAb virtually confirms the diagnosis, though it can occasionally be positive in other autoimmune thyroid conditions.

When Is TRAb Testing Ordered?

TRAb measurement is not a routine screening test. I typically order it under these circumstances:

• To differentiate Graves' disease from other causes of hyperthyroidism (e.g., toxic nodular goiter, thyroiditis)
• To predict relapse after antithyroid drug therapy is stopped
• To evaluate risk of neonatal hyperthyroidism in pregnant women with a history of Graves' disease
• To monitor response to radioiodine or thyroid surgery

Reference Ranges for TRAb

TRAb results are usually reported as a titre (e.g., IU/L) or as a dichotomous result (positive/negative). Note that cut-offs vary between laboratories. The table below shows typical values—always interpret within your lab's reference.

Age- and gender-specific reference ranges are not typically used for TRAb. Levels are not influenced by pregnancy, though monitoring is critical in expectant mothers.

What Does a Positive TRAb Mean?

A positive TRAb indicates that autoimmune stimulation of the thyroid is likely driving the hyperthyroidism. In my clinical practice, I often see patients who are relieved to finally have a clear diagnosis. Positive results correlate with disease activity and can predict relapses if medication is withdrawn.

However, a small percentage of patients with Graves’ disease may be TRAb‐negative due to assay limitations or low antibody concentration. Conversely, TRAb can be transiently positive in autoimmune thyroiditis. That’s why I always interpret results alongside TSH, free T4, free T3, and a thyroid ultrasound.

TRAb During Pregnancy

Maternal TRAb crosses the placenta and can stimulate the fetal thyroid, causing neonatal hyperthyroidism. My patients with known Graves' disease are monitored every 4–6 weeks during pregnancy. If TRAb levels rise above 3–5 IU/L after 24 weeks, the baby is at higher risk and needs close neonatal surveillance.

Difference Between TRAb and TSI

TRAb is a general term that includes both stimulating (TSI) and blocking (TBII) antibodies. Most commercial TRAb assays measure total binding (both types). TSI specifically measures the stimulatory activity. While TRAb is sufficient for diagnosis, TSI assays are sometimes used in research or for prognostic prediction.

How Is TRAb Testing Performed?

It’s a simple blood draw from a vein in your arm. No special preparation is needed—fasting is not required. However, you should inform your doctor if you are taking biotin supplements, as high doses can interfere with immunoassay methods. Results usually take a few days.

Can TRAb Levels Change Over Time?

Absolutely. With antithyroid medication (methimazole or propylthiouracil), TRAb levels often decrease. If levels fall to normal, the chance of remission is higher. In my experience, patients who remain TRAb‐positive after 12–18 months of therapy are less likely to achieve sustained remission without definitive treatment.

Limitations of the TRAb Test

• False negative in 5–10% of Graves’ disease cases
• False positive in some autoimmune thyroiditis or after radioiodine therapy
• Assay variability between manufacturers

Living with Graves’ Disease

A diagnosis of Graves’ disease can feel overwhelming, but effective treatments exist—medication, radioactive iodine, or surgery. Regular TRAb monitoring helps guide decisions. I encourage my patients to also watch for eye symptoms and to keep up with thyroid function tests. With proper management, most people lead full, healthy lives.